CYLOGENE UK LIMITED

Active London

Wholesale of pharmaceutical goods

1 employees website.com
Wholesale of pharmaceutical goods
C

CYLOGENE UK LIMITED

Wholesale of pharmaceutical goods

Founded 27 Nov 2020 Active London, England 1 employees website.com
Wholesale of pharmaceutical goods

Previous Company Names

CYRATEK UK LIMITED 16 Mar 2021 — 25 Mar 2021
ENBIOTECH LIMITED 27 Nov 2020 — 16 Mar 2021
Accounts Submitted 9 Jul 2025 Next due 31 Aug 2026 3 months remaining
Confirmation Submitted 28 Nov 2025 Next due 11 Dec 2026 7 months remaining
Net assets £-27K £2K 2024 year on year
Total assets £2K £5K 2024 year on year
Total Liabilities £28K £3K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

253 Gray's Inn Road London WC1X 8QT England

Full company profile for CYLOGENE UK LIMITED (13046935), an active company based in London, England. Incorporated 27 Nov 2020. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£1.72k

Decreased by £4.80k (-74%)

Net Assets

-£26.68k

Decreased by £2.30k (-9%)

Total Liabilities

£28.40k

Decreased by £2.50k (-8%)

Turnover

N/A

Employees

1

Debt Ratio

1649%

Increased by 1175 (+248%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active
Status
Piero Theodore SoteriouDirectorBritishEngland7227 Nov 2020Active

Shareholders

Shareholders (1)

Piero Theodore Soteriou
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Piero Theodore Soteriou

British

Active
Notified 27 Nov 2020
Residence England
DOB June 1953
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
28 Nov 2025Confirmation StatementConfirmation statement made on 27 Nov 2025 with updates
9 Jul 2025AccountsAnnual accounts made up to 30 Nov 2024
4 Dec 2024Confirmation StatementConfirmation statement made on 27 Nov 2024 with updates
2 Sept 2024AccountsAnnual accounts made up to 30 Nov 2023
29 Nov 2023Confirmation StatementConfirmation statement made on 27 Nov 2023 with updates
28 Nov 2025 Confirmation Statement

Confirmation statement made on 27 Nov 2025 with updates

9 Jul 2025 Accounts

Annual accounts made up to 30 Nov 2024

4 Dec 2024 Confirmation Statement

Confirmation statement made on 27 Nov 2024 with updates

2 Sept 2024 Accounts

Annual accounts made up to 30 Nov 2023

29 Nov 2023 Confirmation Statement

Confirmation statement made on 27 Nov 2023 with updates

Recent Activity

Latest Activity

Confirmation statement made on 27 Nov 2025 with updates

5 months ago on 28 Nov 2025

Annual accounts made up to 30 Nov 2024

10 months ago on 9 Jul 2025

Confirmation statement made on 27 Nov 2024 with updates

1 years ago on 4 Dec 2024

Annual accounts made up to 30 Nov 2023

1 years ago on 2 Sept 2024

Confirmation statement made on 27 Nov 2023 with updates

2 years ago on 29 Nov 2023